Everyone knows that the more prescription drugs cost, the better they work, yes? So what to do about the patent cliff? Buy up companies in emerging markets? Gamble on unproven biotechs? Prescott Pharmaceuticals is no different. After all, as its patents expire on key-selling drugs, so will many of the people who took them. That’s called a dwindling patient population.
